These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9566437)

  • 1. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease.
    Friedman J
    Neurology; 1998 Apr; 50(4):1195-6. PubMed ID: 9566437
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease.
    Wolters EC; Jansen EN; Tuynman-Qua HG; Bergmans PL
    Neurology; 1996 Oct; 47(4):1085-7. PubMed ID: 8857751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine for l-dopa-induced psychosis in PD.
    Weiner WJ; Minagar A; Shulman LM
    Neurology; 2000 Apr; 54(7):1538. PubMed ID: 10751276
    [No Abstract]   [Full Text] [Related]  

  • 4. Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease.
    Breier A; Sutton VK; Feldman PD; Kadam DL; Ferchland I; Wright P; Friedman JH
    Biol Psychiatry; 2002 Sep; 52(5):438-45. PubMed ID: 12242060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of olanzapine in the levodopa-induced psychosis in patients with Parkinson's disease].
    Chacón JR; Durán E; Durán JA; Alvarez M
    Neurologia; 2002 Jan; 17(1):7-11. PubMed ID: 11834192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: results of an open label pilot study.
    Friedman JH; Goldstein S; Jacques C
    Clin Neuropharmacol; 1998; 21(5):285-8. PubMed ID: 9789708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ziprasidone in Parkinson's disease psychosis.
    Connemann BJ; Schönfeldt-Lecuona C
    Can J Psychiatry; 2004 Jan; 49(1):73. PubMed ID: 14763682
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine treatment of methamphetamine psychosis.
    Misra LK; Kofoed L; Oesterheld JR; Richards GA
    J Clin Psychopharmacol; 2000 Jun; 20(3):393-4. PubMed ID: 10831035
    [No Abstract]   [Full Text] [Related]  

  • 9. Aripiprazole and Parkinson's disease psychosis.
    Schönfeldt-Lecuona C; Connemann BJ
    Am J Psychiatry; 2004 Feb; 161(2):373-4. PubMed ID: 14754792
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of olanzapine in Parkinsonian dopaminergic psychosis].
    Durán-Ferreras E; Chacón-Peña JR; Durán-Quintana JA
    Rev Neurol; 2002 Oct 1-15; 35(7):691-6. PubMed ID: 12389159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine for l-dopa-induced psychosis in PD.
    Fernandez HH
    Neurology; 2000 Sep; 55(6):899. PubMed ID: 10994027
    [No Abstract]   [Full Text] [Related]  

  • 12. Worsening of motor features of parkinsonism with olanzapine.
    Molho ES; Factor SA
    Mov Disord; 1999 Nov; 14(6):1014-6. PubMed ID: 10584679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine treatment for dopaminergic-induced hallucinations.
    Ondo WG; Levy JK; Vuong KD; Hunter C; Jankovic J
    Mov Disord; 2002 Sep; 17(5):1031-5. PubMed ID: 12360554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine: a proarrhythmic drug?
    Gupta N; Malhotra P
    Can J Psychiatry; 2002 Sep; 47(7):683-4. PubMed ID: 12355682
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia.
    Marsh L; Lyketsos C; Reich SG
    Psychosomatics; 2001; 42(6):477-81. PubMed ID: 11815682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent psychosis after a single ingestion of 'ecstasy'.
    Van Kampen J; Katz M
    Psychosomatics; 2001; 42(6):525-7. PubMed ID: 11815690
    [No Abstract]   [Full Text] [Related]  

  • 17. Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.
    Llorca PM; Vaiva G; Lancon C
    Can J Psychiatry; 2001 Feb; 46(1):87-8. PubMed ID: 11221497
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine and neuroleptic malignant syndrome.
    Tofler I
    Psychosomatics; 2002; 43(6):505-6; author reply 506. PubMed ID: 12444237
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of Parkinson disease.
    Mandanas L
    J Am Board Fam Pract; 1998; 11(2):171. PubMed ID: 9542714
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine for psychosis in Parkinson's disease.
    Sa DS; Lang AE
    Neurology; 2001 Jun; 56(12):1781. PubMed ID: 11425961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.